Showing 1 - 7 results of 7 for search 'Matthew J Memoli', query time: 0.03s Refine Results
  1. 1
    Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine

    Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine by Luca T. Giurgea, David M. Morens, Jeffery K. Taubenberger, Matthew J. Memoli

    Published 2020-07-01
    Get full text
    Article
  2. 2
    A comparative analysis of COVID-19 seroprevalence rates, observed infection rates, and infection-related mortality

    A comparative analysis of COVID-19 seroprevalence rates, observed infection rates, and infection-related mortality by Eric W. Ford, Kunal N. Patel, Holly Ann Baus, Shannon Valenti, Jennifer A. Croker, Robert P. Kimberly, Steven E. Reis, Matthew J. Memoli

    Published 2025-01-01
    Get full text
    Article
  3. 3
    The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine

    The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine by Luca T. Giurgea, Jae-Keun Park, Kathie-Anne Walters, Kelsey Scherler, Adriana Cervantes-Medina, Ashley Freeman, Luz Angela Rosas, John C. Kash, Jeffery K. Taubenberger, Matthew J. Memoli

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers

    Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers by Rachel Bean, Luca T. Giurgea, Alison Han, Lindsay Czajkowski, Adriana Cervantes-Medina, Monica Gouzoulis, Allyson Mateja, Sally Hunsberger, Susan Reed, Rani Athota, Holly Ann Baus, John C. Kash, Jaekeun Park, Jeffery K. Taubenberger, Matthew J. Memoli

    Published 2024-02-01
    Get full text
    Article
  5. 5
    Leveraging CTSA hubs for rapid, large-scale, high-impact research: A case study during a global public health emergency

    Leveraging CTSA hubs for rapid, large-scale, high-impact research: A case study during a global public health emergency by Jennifer A. Croker, Shannon Valenti, Holly Ann Baus, Eric W. Ford, David Mathias, Laurel Yasko, Dan McGaughey, Tony Smith, Katherine Underwood, Jennifer Avolio, Kaitlyn Sadtler, Matthew J. Memoli, Robert P. Kimberly, Steven E. Reis

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trialResearch in context

    Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trialResearch in conte... by DeAnna J. Friedman-Klabanoff, Megan Birkhold, Mara T. Short, Timothy R. Wilson, Claudio R. Meneses, Joshua R. Lacsina, Fabiano Oliveira, Shaden Kamhawi, Jesus G. Valenzuela, Sally Hunsberger, Allyson Mateja, Gregory Stoloff, Olga Pleguezuelos, Matthew J. Memoli, Matthew B. Laurens

    Published 2022-12-01
    Get full text
    Article
  7. 7
    Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients

    Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients by Ainhoa Pérez-Díez, Xiangdong Liu, Stephanie Calderon, Ashlynn Bennett, Andrea Lisco, Anela Kellog, Frances Galindo, Matthew J. Memoli, Joseph M. Rocco, Brian P. Epling, Elizabeth Laidlaw, Mike C. Sneller, Maura Manion, Glenn W. Wortmann, Rita Poon, Princy Kumar, Irini Sereti

    Published 2024-04-01
    Get full text
    Article

Search Tools: